Olive Polyphenols and the Metabolic Syndrome.

Bandhita Saibandith, Jeremy P E Spencer, Ian R Rowland, Daniel M Commane

Journal: Molecules (Basel, Switzerland) 2018;22(7):1082

PMID: 28661446

Plain Language Summary

plain language summary logo

Up to 25% of the world’s population has metabolic syndrome (MetS), characterised by a combination of high blood pressure, high blood sugar, obesity and abnormal levels of fats in the blood. People with MetS have an increased risk of developing type 2 diabetes and heart disease. The development of MetS is related to modifiable diet and lifestyle factors. This review presents evidence from previous studies investigating the relationship between consumption of olive products, and aspects of MetS, and discusses potential mechanisms linking olive consumption to improvements in markers of health. The authors found good evidence from previous human studies showing that the consumption of olives and olive oil lowers blood pressure in people diagnosed with high blood pressure. There is also good evidence that olives and olive oil can improve blood glucose levels in those with prediabetes and improve markers of lipid peroxidation. There is limited, but promising evidence for effects on dyslipidaemia and the inhibition of weight gain. Studies that used extra virgin olive oil (EVOO) used doses of up to 50g per day, well above the amount that is consumed habitually in most diets. Further evidence is needed to confirm the mechanisms and benefits of olive polyphenols, but the authors suggest that they may explain some of the metabolic benefits associated with a Mediterranean diet.

Abstract

Here, the effects of consuming polyphenol-rich olive products, including olive leaves, their crude extract, and extra virgin olive oil, on aspects of the metabolic syndrome are reviewed. We have sought to summarize the available scientific evidence from dietary intervention trials demonstrating a role for these phytochemicals in ameliorating aberrant glucose metabolism, high blood pressure and elevated blood lipids, and we discuss the potential mechanisms underpinning these observations. Searches for relevant literature published in English were conducted via PubMed and Science Direct. Based on published dietary intervention studies, there is convincing evidence to show that olive polyphenols, independently of olive lipids, reduce risk factors for metabolic syndrome, in particular by improving blood sugar and blood pressure control, and in reducing low density lipoprotein oxidation. There is more limited evidence to suggest that the consumption of olive polyphenols or related products can reduce body weight and visceral fat or impede weight gain, and similarly there are some limited data suggesting improved lipid profiles. There is some mechanistic data to support observations made in human volunteers, but further work is needed in this area. The consumption of olive polyphenols within the context of a healthy pattern of food intake may, in part, explain the reduced risk of metabolic disease associated with adherence to the Mediterranean diet.

Address: Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry Food and Pharmacy, University of Reading, Whiteknights, Reading RG6 6AH, UK. [email protected].; Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry Food and Pharmacy, University of Reading, Whiteknights, Reading RG6 6AH, UK. [email protected].; Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry Food and Pharmacy, University of Reading, Whiteknights, Reading RG6 6AH, UK. [email protected].; Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, School of Chemistry Food and Pharmacy, University of Reading, Whiteknights, Reading RG6 6AH, UK. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.